Erlotinib Completed Phase 1 Trials for Chemoprevention / Cholangiocarcinomas / Primary Sclerosing Cholangitis (PSC) / Trisomy 7 Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT00955149Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)